HCA Healthcare (NYSE:HCA) Rating Lowered to Buy at StockNews.com

HCA Healthcare (NYSE:HCAGet Rating) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday.

A number of other equities research analysts have also issued reports on HCA. BMO Capital Markets lowered shares of HCA Healthcare from a “market perform” rating to an “underperform” rating and reduced their target price for the stock from $233.00 to $160.00 in a report on Wednesday, July 6th. Cowen reduced their price objective on shares of HCA Healthcare to $238.00 in a report on Monday, July 25th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of HCA Healthcare from $306.00 to $200.00 and set a “buy” rating on the stock in a report on Thursday, July 7th. Loop Capital initiated coverage on shares of HCA Healthcare in a report on Thursday, June 16th. They issued a “buy” rating and a $240.00 price objective on the stock. Finally, Credit Suisse Group raised their price objective on shares of HCA Healthcare from $230.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, July 25th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $239.14.

HCA Healthcare Trading Down 2.4 %

Shares of HCA stock traded down $4.78 during trading hours on Thursday, hitting $194.06. The company had a trading volume of 1,071,820 shares, compared to its average volume of 1,751,495. The company’s fifty day moving average is $205.76 and its 200 day moving average is $214.90. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.55 and a quick ratio of 1.32. HCA Healthcare has a fifty-two week low of $164.47 and a fifty-two week high of $279.02. The stock has a market capitalization of $55.70 billion, a PE ratio of 9.33, a price-to-earnings-growth ratio of 1.53 and a beta of 1.72.

HCA Healthcare (NYSE:HCAGet Rating) last issued its quarterly earnings data on Friday, July 22nd. The company reported $4.21 EPS for the quarter, topping the consensus estimate of $3.67 by $0.54. The firm had revenue of $14.82 billion for the quarter, compared to analyst estimates of $14.73 billion. HCA Healthcare had a net margin of 10.83% and a return on equity of 833.68%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business posted $4.37 EPS. Research analysts expect that HCA Healthcare will post 17.09 earnings per share for the current fiscal year.

Insider Transactions at HCA Healthcare

In other news, major shareholder Patricia F. Elcan purchased 325 shares of the stock in a transaction dated Monday, July 25th. The stock was acquired at an average cost of $198.66 per share, for a total transaction of $64,564.50. Following the completion of the acquisition, the insider now directly owns 89,337 shares in the company, valued at approximately $17,747,688.42. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.50% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

A number of institutional investors have recently bought and sold shares of the stock. Ellevest Inc. grew its holdings in HCA Healthcare by 33.6% in the first quarter. Ellevest Inc. now owns 187 shares of the company’s stock valued at $47,000 after purchasing an additional 47 shares during the period. Brown Brothers Harriman & Co. grew its stake in HCA Healthcare by 12.8% during the second quarter. Brown Brothers Harriman & Co. now owns 413 shares of the company’s stock worth $69,000 after buying an additional 47 shares during the period. Veriti Management LLC grew its stake in HCA Healthcare by 4.0% during the first quarter. Veriti Management LLC now owns 1,297 shares of the company’s stock worth $325,000 after buying an additional 50 shares during the period. Oliver Luxxe Assets LLC grew its stake in HCA Healthcare by 0.4% during the fourth quarter. Oliver Luxxe Assets LLC now owns 13,470 shares of the company’s stock worth $3,461,000 after buying an additional 51 shares during the period. Finally, Glassman Wealth Services grew its stake in HCA Healthcare by 28.7% during the second quarter. Glassman Wealth Services now owns 233 shares of the company’s stock worth $39,000 after buying an additional 52 shares during the period. 65.75% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.